A new peer-reviewed Japanese study claims around 70 percent of people who died in Japan after receiving a Pfizer COVID-19 jab passed away within the first 10 days of the shot.

“After BNT162b2 mRNA vaccination, 1,311 deaths were identified in Group 1, including 662 males and 649 females, with a mean (standard deviation) age of 82.8 (8.5) years. A total of 247 deaths were identified in Group 2, with 155 males and 92 females, with a mean age of 47.1 (13.7) years. The percentage of reported cases that experienced death within 10 days after vaccination was 71% in Group 1 and 70% in Group 2,” the study, published in the Cureus journal on December 7th, writes.

Dr. Kat Lindley writes:

Around 70 percent of people who died in Japan after receiving a Pfizer COVID-19 vaccine lost their lives in the first 10 days following the jab, according to a recent study.

The peer-reviewed Japanese study, published in the Cureus journal on Dec. 7, looked at the association between Pfizer COVID-19 vaccination and deaths within 10 days of vaccination.

The risk period was defined as within 10 days of vaccination, with vaccination day being Day 1, and the control period defined as 11 to 180 days after vaccination.

The analysis was divided into two groups: Group 1 representing individuals aged 65 and above and Group 2, which included people aged 64 and below.

The researcher identified 1,311 deaths in Group 1, which included 662 males and 649 females. In Group 2, the team identified 247 deaths—155 males and 92 females.

“The percentage of reported cases that experienced death within 10 days after vaccination was 71 percent in Group 1 and 70 percent in Group 2,” said the study results.

“In Group 1, more women than men died overall from various medical conditions in the first 10 days of vaccination. Following the 10 days, there were more deaths reported of men,” The Epoch Times writes.

“In Group 2, over two times more men died than women from various medical conditions during the first 10 days of vaccination. Overall deaths after the initial 10 days were only slightly higher among men,” the outlet added.

More details from Cureus:

In Group 1, regarding the outcomes in ≥20 cases, the sex ratios during the risk period were lower than those during the control period for conditions including ischemic heart disease, aortic aneurysm/dissection, intracerebral hemorrhage, subarachnoid hemorrhage, cerebral infarction, interstitial lung diseases, pneumonia, aspiration pneumonia/asphyxia, marasmus, and unexplained deaths. The accumulation of these outcomes may have resulted in a lower sex ratio during the risk period for all-cause deaths. As Yamashita et al. indicated in 2022, the reasons for the low sex ratios are believed to be that women’s body weight in Japan is generally lower than that in the USA and European countries and that women’s immune responses to vaccines are stronger than those of men. No significant differences were observed between the sex ratios by period across any of the outcomes. One contributing factor for this is thought to be the limited number of cases for each outcome.

In Group 2, regarding the outcomes in ≥20 cases, the sex ratios during the risk period were higher than those during the control period for conditions including ischemic heart disease, subarachnoid hemorrhage, and unexplained deaths. No significant differences were observed between the sex ratios by period across any of the outcomes. This is thought to be due, in part, to the small number of cases for each outcome. The sex ratio for myocarditis/pericarditis during the risk period was 800, which was eight times higher than that during the control period. However, the number of cases was small (17 cases). Since autopsies were performed in only nine of the 51 cases of unexplained deaths, some myocarditis/pericarditis cases may be included within the unexplained deaths category. Myocarditis is a complication of vaccination, especially in young adults and adolescent males. One contributing factor for the high sex ratio of all-cause deaths during the risk period is thought to be the high number of myocarditis/pericarditis deaths including undiagnosed cases.

“If less than 14 days since [inoculation] you are officially ‘unvaccinated.’ See how that works,” Kelly DNP, a clinical research whistleblower, commented.

The Epoch Times reports:

The data on death numbers for the study were sourced from Japan’s Ministry of Health, Labour, and Welfare (MHLW).

Specifically, cases involving only the BNT162b2 (Pfizer-BioNTech) mRNA vaccination reported between Feb. 17, 2021, and March 12, 2023, were included.

The study does not directly link the deaths with the vaccinations. “The results indicate that the BNT162b2 mRNA vaccination may influence the occurrence of death during the risk period,” said the study.

The author pointed to some of the limitations of the study including that the number of days from vaccination to death may vary depending on treatment, and that the study did not consider the effects of the vaccination after 11 days.

Besides this, the author said the sex-based reporting could have only been performed by a few doctors, and that the mortality rates could not be calculated because the analysis was performed only for deaths after vaccination.

The study had a limited sample size, and hence should be “carefully” interpreted. “Finally, the analysis results should be carefully interpreted because not all deaths reported to the MHLW were related to vaccination. Incidental deaths may be included in the reported deaths.”

The study author stressed that since vaccines are administered to mostly healthy individuals, it should have a “higher level of safety than pharmaceuticals used for treatment and should have an exceptionally low vaccination mortality rate.”

Read the full study at the Cureus journal.

 

Join The Conversation. Leave a Comment.


We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.